mRNA-based therapeutics: powerful and versatile tools to combat diseases

S Qin, X Tang, Y Chen, K Chen, N Fan… - Signal transduction and …, 2022 - nature.com
The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide
range of incurable diseases. Recent rapid advances in biotechnology and molecular …

Nanotechnology-based mRNA vaccines

S Chen, X Huang, Y Xue, E Álvarez-Benedicto… - Nature Reviews …, 2023 - nature.com
Abstract mRNA vaccines have emerged as a revolutionary tool to generate rapid and
precise immune responses against infectious diseases and cancers. Compared with …

mRNA vaccines for infectious diseases—advances, challenges and opportunities

N Pardi, F Krammer - Nature Reviews Drug Discovery, 2024 - nature.com
The concept of mRNA-based vaccines emerged more than three decades ago.
Groundbreaking discoveries and technological advancements over the past 20 years have …

Circular RNA vaccine in disease prevention and treatment

D Niu, Y Wu, J Lian - Signal transduction and targeted therapy, 2023 - nature.com
CircRNAs are a class of single-stranded RNAs with covalently linked head-to-tail topology.
In the decades since its initial discovery, their biogenesis, regulation, and function have …

An mRNA vaccine to prevent genital herpes

S Awasthi, HM Friedman - Translational Research, 2022 - Elsevier
The rapid development of two nucleoside-modified mRNA vaccines that are safe and highly
effective against coronavirus disease 2019 has transformed the vaccine field. The mRNA …

Lipid nanoparticles delivering constitutively active STING mRNA to stimulate antitumor immunity

W Liu, MG Alameh, JF Yang, JR Xu, PJC Lin… - International Journal of …, 2022 - mdpi.com
Treating immunosuppressive tumors represents a major challenge in cancer therapies.
Activation of STING signaling has shown remarkable potential to invigorate the …

Messenger RNA Therapy for Female Reproductive Health

R VanKeulen-Miller, OS Fenton - Molecular Pharmaceutics, 2024 - ACS Publications
Female reproductive health has traditionally been an underrepresented area of research in
the drug delivery sciences. This disparity is also seen in the emerging field of mRNA …

A trivalent HSV-2 gC2, gD2, gE2 nucleoside-modified mRNA-LNP vaccine provides outstanding Protection in mice against genital and non-genital HSV-1 infection …

KP Egan, S Awasthi, G Tebaldi, LM Hook… - Viruses, 2023 - mdpi.com
HSV-1 disease is a significant public health burden causing orofacial, genital, cornea, and
brain infection. We previously reported that a trivalent HSV-2 gC2, gD2, gE2 nucleoside …

Small animal models to study herpes simplex virus infections

MT Hussain, BA Stanfield, DI Bernstein - Viruses, 2024 - mdpi.com
Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) are two of the
most prevalent human viruses worldwide. They are known to cause a variety of diseases …

Advances in mRNA vaccines for viral diseases

Y Huang, X Zhu, X Guo, Y Zhou, D Liu… - Journal of Medical …, 2023 - Wiley Online Library
Since the onset of the pandemic caused by severe acute respiratory syndrome coronavirus
2, messenger RNA (mRNA) vaccines have demonstrated outstanding performance. mRNA …